Literature DB >> 11943239

Factors predicting communication about the diagnosis of maternal breast cancer to children.

Jacqueline Barnes1, Leanda Kroll, Joanna Lee, Olive Burke, Alison Jones, Alan Stein.   

Abstract

OBJECTIVE: To identify factors influencing mothers' communication with their children about their diagnosis and initial treatment.
DESIGN: Cross-sectional cohort.
SETTING: Two breast cancer treatment centres.
SUBJECTS: Thirty-two women with Stage I or Stage II breast cancer with 56 school-aged children. MAIN OUTCOME MEASURES: Semistructured interview regarding timing and extent of communication with children from the time that a problem was first identified to initial treatment, and children's reactions.
RESULTS: Children were most likely to be told about their mother's illness after the diagnosis had been confirmed by biopsy but a minority were told nothing until after surgery and some nothing at all. The information children received did not necessarily include mention of cancer. Predictors of communication were child age, with older children being told earlier and more information, and maternal education, with children of more highly educated mothers being told less. Child gender was not related to communication.
CONCLUSION: Mothers who are being investigated for breast cancer are likely to benefit from the opportunity to consult a supportive professional about communication with their children during all stages of their diagnosis and treatment, but particularly early on in the investigation when they are more reluctant to initiate discussions with their children. At later points, those with children of varying ages may need specific advice on ways to discuss their illness in relation to children's understanding.

Entities:  

Mesh:

Year:  2002        PMID: 11943239     DOI: 10.1016/s0022-3999(02)00296-9

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  7 in total

1.  A qualitative study of decision-making by breast cancer patients about telling their children about their illness.

Authors:  Saran Yoshida; Hiroyuki Otani; Kei Hirai; Akiko Ogata; Asuka Mera; Shiho Okada; Akira Oshima
Journal:  Support Care Cancer       Date:  2009-06-30       Impact factor: 3.603

2.  The Enhancing Connections Program: a six-state randomized clinical trial of a cancer parenting program.

Authors:  Frances Marcus Lewis; Patricia A Brandt; Barbara B Cochrane; Kristin A Griffith; Marcia Grant; Joan E Haase; Arlene D Houldin; Janice Post-White; Ellen H Zahlis; Mary Ellen Shands
Journal:  J Consult Clin Psychol       Date:  2014-11-17

3.  When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Brian L Egleston; Olufunmilayo I Olopade; Mary B Daly; Cynthia W Moore; Colleen B Sands; Helen Schmidheiser; Preethi K Kondamudi; Maia Feigon; Comfort N Ibe; Christopher K Daugherty
Journal:  Cancer       Date:  2012-01-09       Impact factor: 6.860

4.  The impact of parental cancer on preadolescent children (0-11 years) in Western Australia: a longitudinal population study.

Authors:  Angelita Martini; Julia N Morris; Hayley M Jackson; Jeneva L Ohan
Journal:  Support Care Cancer       Date:  2018-09-26       Impact factor: 3.603

Review 5.  The well-being of children impacted by a parent with cancer: an integrative review.

Authors:  Julia N Morris; Angelita Martini; David Preen
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603

6.  Frequency and correlates of symptoms of anxiety and depression among young caregivers of cancer patients: a pilot study.

Authors:  Muhammad Hassan Majeed; Muhammad Abbas Khokhar; Maryam Abid; Awais Raza; Muhammad Nawaz Qaisar; Ali Ahsan Ali; Ahmed Waqas
Journal:  BMC Res Notes       Date:  2018-08-31

7.  Information Needs Assessment among Parents of Children with Cancer.

Authors:  Mohammad Esmail Motlagh; Mehdi Mirzaei-Alavijeh; Seyyed Nasrollah Hosseini
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.